The TREM1+-myeloid-derived cell fusogenicity with glioblastoma cells and pro-inflammatory ability might have a profound impact on transformed cell plasticity, proliferation, immune evasion, metastasis, and development of drug resistance. The gene discussed is TREM1; the disease is glioblastoma.